Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P Biotech ETF
XBI
|
+$284M |
| 2 |
Constellation Brands
STZ
|
+$284M |
| 3 |
Stellantis
STLA
|
+$268M |
| 4 |
VMW
VMware, Inc
VMW
|
+$263M |
| 5 |
NiSource
NI
|
+$234M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.82B |
| 2 |
Apple
AAPL
|
+$1.62B |
| 3 |
UnitedHealth
UNH
|
+$1.03B |
| 4 |
ExxonMobil
XOM
|
+$869M |
| 5 |
Tesla
TSLA
|
+$701M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.19% |
| 2 | Consumer Discretionary | 5.03% |
| 3 | Healthcare | 4.78% |
| 4 | Financials | 4.74% |
| 5 | Communication Services | 2.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ITIC
3601
Investors Title Co
ITIC
$546M
| $228K | ﹤0.01% |
1,510
+147
| +11% | +$22.6K |
|
3602
REX American Resources
REX
$1.42B
| $228K | ﹤0.01% |
15,936
+722
| +5% | +$11.4K |
|
|
BCOV
3603
DELISTED
Brightcove, Inc.
BCOV
| $228K | ﹤0.01% |
51,187
+16,965
| +50% | +$94.7K |
|
3604
Xeris Biopharma Holdings
XERS
$1.39B
| $228K | ﹤0.01% |
139,732
+31,421
| +29% | +$39.3K |
|
|
TEAD
3605
Teads Holding Co
TEAD
$68.7M
| $227K | ﹤0.01% |
54,984
+8,695
| +19% | +$39.4K |
|
|
ORGN
3606
DELISTED
Origin Materials
ORGN
| $227K | ﹤0.01% |
1,772
+832
| +89% | +$123K |
|
|
AGTI
3607
DELISTED
Agiliti Inc
AGTI
| $227K | ﹤0.01% |
14,205
-454
| -3% | -$7.82K |
|
3608
Mission Produce
AVO
$1.11B
| $226K | ﹤0.01% |
20,341
+9,578
| +89% | +$112K |
|
3609
Bowman Consulting
BWMN
$470M
| $226K | ﹤0.01% |
8,286
+5,017
| +153% | +$131K |
|
3610
Invesco DB Agriculture Fund
DBA
$1.23B
| $226K | ﹤0.01% |
11,047
-29,351
| -73% | -$586K |
|
3611
The Joint Corp
JYNT
$118M
| $225K | ﹤0.01% |
13,390
+6,467
| +93% | +$107K |
|
|
ZYXI
3612
DELISTED
Zynex
ZYXI
| $225K | ﹤0.01% |
18,765
+8,302
| +79% | +$108K |
|
|
PCRB
3613
DELISTED
Putnam ESG Core Bond ETF
PCRB
| $225K | ﹤0.01% |
+4,533
| New | +$224K |
|
3614
DHI Group
DHX
$182M
| $224K | ﹤0.01% |
57,806
+28,194
| +95% | +$134K |
|
3615
Levi Strauss
LEVI
$9.44B
| $224K | ﹤0.01% |
+12,293
| New | +$211K |
|
3616
Crescent Energy
CRGY
$3.79B
| $224K | ﹤0.01% |
19,774
+5,993
| +43% | +$69.4K |
|
3617
Microvision
MVIS
$6.21M
| $223K | ﹤0.01% |
83,623
+39,162
| +88% | +$98.9K |
|
|
RAIN
3618
DELISTED
Rain Oncology Inc. Common Stock
RAIN
| $222K | ﹤0.01% |
+25,438
| New | +$235K |
|
3619
Grindr
GRND
$3.08B
| $222K | ﹤0.01% |
+35,740
| New | +$214K |
|
3620
Information Services Group
III
$199M
| $220K | ﹤0.01% |
43,312
+10,156
| +31% | +$52.2K |
|
|
SAL
3621
DELISTED
Salisbury Bancorp, Inc.
SAL
| $220K | ﹤0.01% |
9,129
| – | – |
|
|
BASE
3622
DELISTED
Couchbase
BASE
| $219K | ﹤0.01% |
15,593
+2,431
| +18% | +$35.9K |
|
3623
Mitek Systems
MITK
$754M
| $219K | ﹤0.01% |
22,845
+10,010
| +78% | +$96K |
|
3624
Organogenesis Holdings
ORGO
$305M
| $219K | ﹤0.01% |
102,828
-3,963
| -4% | -$9.79K |
|
3625
Fiverr
FVRR
$321M
| $219K | ﹤0.01% |
6,268
-10,222
| -62% | -$374K |
|
Similar funds
Barclays's Q1 2023 Portfolio in Review
As of Q1 2023, Barclays held 5,603 positions worth $218B, down 2.4% from $223B the previous quarter. Its ten largest holdings account for 47% of the portfolio.
Barclays withdrew a net $25.1B in Q1 2023, closing 541 positions and reducing 1,667 holdings. Its most notable exit was Coupa Software Incorporated, an estimated $128M position sold in full.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 12% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Barclays opened a new position in GE HealthCare worth $40.7M.
- Barclays's largest Q1 2023 buy was GE HealthCare: 496,712 shares worth $40.7M.
- Barclays added most to State Street SPDR S&P Biotech ETF in Q1 2023, an estimated $284M increase.
- Barclays's biggest Q1 2023 reduction was Microsoft, cutting an estimated $1.82B.
- Barclays fully exited Coupa Software Incorporated in Q1 2023, selling an estimated $128M.
- Barclays's ten largest holdings make up 47% of its $218B portfolio in Q1 2023.
- Barclays opened 345 new positions and closed 541 in Q1 2023.
- Barclays's portfolio value fell 2.4% quarter-over-quarter to $218B.
Based on Barclays's 13F filing for Q1 2023, filed 4 May 2023.